276 related articles for article (PubMed ID: 2652473)
1. Comparison of cyclosporine (CSA) blood levels and RIA/HPLC ratios among renal transplant patients with normal allograft function, CSA nephrotoxicity or rejection.
Veremis SA; Maddux MS; Tang IY; Millner SN; Prasad R; Pollak R; Mozes MF
Transplant Proc; 1989 Feb; 21(1 Pt 2):1476-7. PubMed ID: 2652473
[No Abstract] [Full Text] [Related]
2. Cyclosporine and metabolites in blood from renal allograft recipients with nephrotoxicity, rejection, or good renal function: comparative high-performance liquid chromatography and monoclonal radioimmunoassay studies.
Rosano TG; Pell MA; Freed BM; Dybas MT; Lempert N
Transplant Proc; 1988 Apr; 20(2 Suppl 2):330-8. PubMed ID: 3284076
[No Abstract] [Full Text] [Related]
3. Clinical diagnosis and management of the renal transplant recipient with cyclosporine nephrotoxicity.
Diethelm AG
Transplant Proc; 1986 Apr; 18(2 Suppl 1):82-91. PubMed ID: 3515700
[TBL] [Abstract][Full Text] [Related]
4. Ciclosporin monitoring in kidney-transplanted children: high-performance liquid chromatography versus radioimmunoassay.
Khoss AE; Hamilton G; Illievich V; Mühlbacher F; Roth E; Steger H; Wladika W; Howanietz H; Balzar E
Child Nephrol Urol; 1988-1989; 9(1-2):42-5. PubMed ID: 3075152
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the clinical, histopathologic, cytologic, and biochemical features of renal transplant rejection, cyclosporine A nephrotoxicity, and stable renal function.
Taube D; Neild G; Hobby P; Holt D; Welsh K; Cameron JS
Transplant Proc; 1985 Aug; 17(4 Suppl 1):179-84. PubMed ID: 3895658
[No Abstract] [Full Text] [Related]
6. Cyclosporine monitoring with polyclonal and specific monoclonal antibodies during episodes of renal allograft dysfunction.
Holt DW; Marsden JT; Johnston A; Taube DH
Transplant Proc; 1989 Feb; 21(1 Pt 2):1482-4. PubMed ID: 2652475
[No Abstract] [Full Text] [Related]
7. Monitoring of cyclosporine blood levels with polyclonal and monoclonal assays during episodes of renal graft dysfunction.
Martinez L; Foradori A; Vaccarezza A; Martinez P; Rodriguez L
Transplant Proc; 1989 Feb; 21(1 Pt 2):1490-1. PubMed ID: 2652479
[No Abstract] [Full Text] [Related]
8. Definition, diagnosis, and management of rejection in the second to sixth months posttransplant--an overview.
Matas AJ; Tellis VA; Quinn T; Soberman R; Veith FJ
Transplant Proc; 1986 Apr; 18(2 Suppl 1):141-50. PubMed ID: 3515682
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of cyclosporine levels one to six months posttransplant.
Steinmuller DR
Transplant Proc; 1986 Apr; 18(2 Suppl 1):158-67. PubMed ID: 3515684
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous monitoring of cyclosporin in blood and plasma with four analytical methods: a clinical evaluation.
Lindholm A; Henricsson S
Transplant Proc; 1989 Feb; 21(1 Pt 2):1472-4. PubMed ID: 2652471
[No Abstract] [Full Text] [Related]
11. Chronic cyclosporine nephrotoxicity in renal transplantation: is it the effect of preservation?
Kumar MS; Samhan M; John P; al-Adnani MS; Abouna GM
Transplant Proc; 1989 Feb; 21(1 Pt 2):1552-3. PubMed ID: 2652503
[No Abstract] [Full Text] [Related]
12. Serum cyclosporine kinetic profile. Failure to correlate with nephrotoxicity or rejection episodes following sequential immunotherapy for renal transplantation.
Sommer BG; Sing DE; Henry ML; Ferguson RM; Orosz CG
Transplantation; 1988 Jan; 45(1):86-90. PubMed ID: 3276069
[TBL] [Abstract][Full Text] [Related]
13. Is there a therapeutic range for monitoring plasma cyclosporin in renal allograft recipients?
Ubhi CS; Woodhouse L; Guillou PJ; Giles GR
Nephrol Dial Transplant; 1988; 3(6):814-9. PubMed ID: 3147426
[TBL] [Abstract][Full Text] [Related]
14. Failure of 125I-tracer selective monoclonal antibody levels on a whole blood matrix to predict rejection or nephrotoxic episodes in renal transplant patients under anti-lymphocyte globulin and prednisone therapy.
Stiller C; Keown P
Transplant Proc; 1990 Jun; 22(3):1253-4. PubMed ID: 2349687
[No Abstract] [Full Text] [Related]
15. Analysis of cyclosporin A (CsA) concentrations by fluorescence polarization immunoassay (FPIA): comparison with radio immunoassay (RIA) and liquid chromatography (HPLC).
Mraz W; Müller C; Molnar B; Knedel M
Transplant Proc; 1989 Feb; 21(1 Pt 1):885-7. PubMed ID: 2650289
[No Abstract] [Full Text] [Related]
16. Therapeutic cyclosporine monitoring: comparison of radioimmunoassay and high-performance liquid chromatography methods in organ transplant recipients.
Hirvisalo EL; Kivistö KT; Neuvonen PJ
Ther Drug Monit; 1990 Jul; 12(4):353-8. PubMed ID: 2396309
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporine monitoring in kidney and liver transplant patients: comparison between radioimmunoassay (37 degrees C plasma) and high-performance liquid chromatography (whole blood) measurements.
Mojaverian P; Green PJ
Transplant Proc; 1988 Apr; 20(2 Suppl 2):414-8. PubMed ID: 3284085
[No Abstract] [Full Text] [Related]
18. The use of triple therapy to minimize cyclosporine (CsA) nephrotoxicity in renal transplantation.
Landsberg DN; Rae A; Chiu A; Werb R; Taylor P; Chan-Yan C; Manson AD
Transplant Proc; 1989 Feb; 21(1 Pt 2):1550-1. PubMed ID: 2652502
[No Abstract] [Full Text] [Related]
19. [Measuring cyclosporin in immunosuppressive treatment following liver and heart transplantation].
Hamilton G; Roth E; Mühlbacher F; Funovics J; Piza F; Schindler J; Woloszcuk W; Havel M; Laczkovics A
Wien Klin Wochenschr; 1986 Dec; 98(24):820-4. PubMed ID: 3548080
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the clinical utility of the radioimmunoassay, high-performance liquid chromatography, and TDx cyclosporine assays in outpatient renal transplant recipients.
Schroeder TJ; Brunson ME; Pesce AJ; Hindenlang LL; Mauser PA; Ruckrigl DI; Weibel ML; Wadih G; First MR
Transplantation; 1989 Feb; 47(2):262-6. PubMed ID: 2645710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
